Search

everythinglearnresearchcommunity

for

Search:↓

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Blocking LFA-1 prevents hair loss in mice.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Plucked hair follicles can help diagnose scalp lupus.

taVNS reduces vitiligo symptoms in mice.

Skin bacteria can help wound healing by activating certain immune cells.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Reducing CD8+ T cell growth can stabilize alopecia areata.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.